Deucravacitinib 6 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 6 mg
Reference Brands: Sotyktu (USA/EU)
Category: Immune Disorder
Deucravacitinib is a Immune Disorder product available as Tablet in strengths 6 mg. It corresponds to the reference brand Sotyktu (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Deucravacitinib is an oral targeted therapy used for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It belongs to a newer class of small-molecule medicines known as tyrosine kinase 2 (TYK2) inhibitors. By selectively blocking the TYK2 pathway, deucravacitinib helps regulate immune signaling involved in inflammatory skin disease, leading to reduced plaque formation, redness, and scaling. Its selective mechanism allows more focused immune modulation compared with broader immunosuppressive treatments.
The medicine is taken once daily by mouth, which offers a convenient dosing approach and can support better patient adherence compared to injectable therapies. Clinical studies have shown meaningful improvement in skin clearance and symptom control in many patients with plaque psoriasis. Deucravacitinib is generally prescribed under specialist supervision, with monitoring for potential adverse effects and drug interactions. It is marketed under the brand name Sotyktu and was developed by Bristol Myers Squibb. The product is approved in several major markets for systemic psoriasis treatment.
Deucravacitinib — third party manufacturing & bulk supply
Deucravacitinib 6 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Deucravacitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Deucravacitinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Deucravacitinib is used for the treatment of moderate to severe plaque psoriasis in adults who require systemic therapy or phototherapy.
It is a small-molecule synthetic TYK2 (tyrosine kinase 2) inhibitor designed to selectively block immune signaling pathways involved in inflammation.
The trade name is Sotyktu.
It is developed and marketed by Bristol Myers Squibb.
The generic name is deucravacitinib.
The brand name is Sotyktu.
It is manufactured by Bristol Myers Squibb through approved global manufacturing facilities (primarily USA and EU compliant sites).
Related Products
Etrasimod Arginine
Strength:
2 mg, 4 mg, 6 mg
Form: Tablets
Reference Brands: Velsipity (USA)
View Details
Fostamatinib Disodium
Strength:
100 mg, 150 mg
Form: Tablets
Reference Brands: Tavalisse (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
